| Literature DB >> 26656120 |
Shayla Hesse1, Frederick H Neill2, Mary K Estes3, Sreejesh Shanker4, B V Venkataram Prasad5, Jennifer Ferreira6, Robert L Atmar7.
Abstract
The performance of an assay to detect antibodies to a norovirus nonstructural fusion protein, designated VPR and consisting of three proteins (GI.1 virus protein genome-linked [VPg], a virus protease, and an RNA-dependent RNA polymerase), was evaluated. The assay sensitivity and specificity were 74.5% and >95%, respectively, for identifying GI.1 norovirus infection among persons who received either a monovalent GI.1 norovirus virus-like particle (VLP) vaccine or placebo by the intranasal route followed by an oral live GI.1 norovirus challenge.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26656120 PMCID: PMC4744919 DOI: 10.1128/CVI.00595-15
Source DB: PubMed Journal: Clin Vaccine Immunol ISSN: 1556-679X